Patents Assigned to Elastogenesis, LLC
  • Publication number: 20210277072
    Abstract: The present invention describes novel plant derived elastin-like peptides and peptidomimetics that may serve as functional ligands for elastin receptors and stimulate elastogenesis. The novel plant derived peptides provide an alternative (non-animal derived) source of GXXPG (SEQ ID NO. 2) containing peptides. The present invention also describes therapeutic compositions containing novel plant derived peptides or peptidomimetics useful in stimulating elastogenensis and capillary dilatation. The therapeutic compositions of the present invention that comprise novel plant derived peptides or peptidomimetics may be combined with other therapeutic agents.
    Type: Application
    Filed: October 15, 2020
    Publication date: September 9, 2021
    Applicants: ELASTOGENESIS, LLC, THE HOSPITAL FOR SICK CHILDREN
    Inventors: Felipe JIMENEZ, Thomas MITTS, Aleksander HINEK
  • Patent number: 10844101
    Abstract: The present invention describes novel plant derived elastin-like peptides and peptidomimetics that may serve as functional ligands for elastin receptors and stimulate elastogenesis. The novel plant derived peptides provide an alternative (non-animal derived) source of GXXPG (SEQ ID NO. 2) containing peptides. The present invention also describes therapeutic compositions containing novel plant derived peptides or peptidomimetics useful in stimulating elastogenensis and capillary dilatation. The therapeutic compositions of the present invention that comprise novel plant derived peptides or peptidomimetics may be combined with other therapeutic agents.
    Type: Grant
    Filed: November 27, 2018
    Date of Patent: November 24, 2020
    Assignees: Elastogenesis, LLC, The Hospital for Sick Children
    Inventors: Felipe Jimenez, Thomas Mitts, Aleksander Hinek